TrianglePUBLICATIONS · 30179569
Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2018 Oct 20
- First author
- Evens AM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Evens AM
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Helenowski IB
- type
- Author
- name
- Fanale M
- type
- Author
- name
- Smith SM
- type
- Author
- name
- Jovanovic BD
- type
- Author
- name
- Bociek GR
- type
- Author
- name
- Klein AK
- type
- Author
- name
- Winter JN
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Hamlin PA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Evens AM
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Helenowski IB
- type
- Author
- name
- Fanale M
- type
- Author
- name
- Smith SM
- type
- Author
- name
- Jovanovic BD
- type
- Author
- name
- Bociek GR
- type
- Author
- name
- Klein AK
- type
- Author
- name
- Winter JN
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Hamlin PA
- type
- Author
- bibliography ids
- nci-bib-37c566b362e6e160fc8c9919
- book metadata
- content sha256
- 0e089a04c402c2fb77e511e5040475a8b83a660f80b86870f58df996670d4785
- document type
- citation
- dois
- 10.1200/JCO.2018.79.0139
- electronic publication date
- display
- 2018 Sep 4
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30179569
- immutable id
- pubmed:30179569@0e089a04c402c2fb77e511e5040475a8b83a660f80b86870f58df996670d4785
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3015-3022
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30179569
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- c416f49f8bb38ecdb4197fa428d6a5da4a717caf42f9db403f948695de95712c
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2018 Oct 20
- precision
- day
- year
- 2018
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.
Preserved source evidence · Not medical advice